Share of people with HIV who receive antiretroviral therapy in Portugal
Portugal: Share of people with HIV who receive antiretroviral therapy was 82.0% in 2017. ▲ Rising
Share of people with HIV who receive antiretroviral therapy in Portugal, 2000–2017
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
The most recent figure for share of people with hiv who receive antiretroviral therapy in Portugal is 82.0%, measured in 2017. That is the highest value across all 18 years on record.
The figure is up 12.3% on the previous year and up 100.0% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Portugal peaked at 82.0% in 2017 and was at its lowest, 16.0%, in 2000.
Portugal ranks 45th of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Share of people with HIV who receive antiretroviral therapy in Portugal, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 16.0% | — |
| 2001 | 20.0% | +25.0% |
| 2002 | 24.0% | +20.0% |
| 2003 | 28.0% | +16.7% |
| 2004 | 32.0% | +14.3% |
| 2005 | 35.0% | +9.4% |
| 2006 | 38.0% | +8.6% |
| 2007 | 41.0% | +7.9% |
| 2008 | 43.0% | +4.9% |
| 2009 | 46.0% | +7.0% |
| 2010 | 51.0% | +10.9% |
| 2011 | 55.0% | +7.8% |
| 2012 | 59.0% | +7.3% |
| 2013 | 63.0% | +6.8% |
| 2014 | 67.0% | +6.3% |
| 2015 | 70.0% | +4.5% |
| 2016 | 73.0% | +4.3% |
| 2017 | 82.0% | +12.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.3% | 16.0% | 46.0% | 10 |
| 2010s | 65.0% | 51.0% | 82.0% | 8 |
Countries ranked near Portugal
- 44 Nigeria 83.0% compare
- 45 Burkina Faso 82.0% compare
- 45 Ecuador 82.0% compare
- 45 Mozambique 82.0% compare
More health data for Portugal
- Un projection of annual infant deaths, annual growth rate -2.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1616 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,112 deaths per 1,000 people (2090)
- Number of infants who die before age 1 38 deaths (2100)
- Population ages 30-34, female, annual growth rate -0.3474 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0264 units per person (2025)
- Population ages 30-34, male, annual growth rate 0.1616 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0268 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Portugal?
- Share of people with hiv who receive antiretroviral therapy in Portugal was 82.0% in 2017, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Portugal?
- The highest recorded value was 82.0% in 2017.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Portugal?
- The lowest recorded value was 16.0% in 2000.
- How does Portugal rank for share of people with hiv who receive antiretroviral therapy?
- Portugal ranks 45th out of 143 countries with data for 2017.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Portugal?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is rising.
- Where does this Portugal data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.